September 11th 2024
Wendie Berg. MD, PhD, explains new breast density reporting standards, cancer risks, and the importance of supplemental imaging for dense breast tissue.
2024 Neuromuscular Summit
November 20, 2024
View More
Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments
View More
Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions
View More
16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 3, 2025
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents
View More
Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine
View More
Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings
View More
Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine
View More
Clinicians Not Fully Identifying Postmenopausal Women at Risk for Invasive Breast Cancer
July 2nd 2011Breast cancer causes more than 40,000 deaths annually and is only second to lung cancer in cause of cancer deaths in women in the United States. Since early identification is key to prompt treatment and the best prognosis, it is crucial to identify women at risk.
Read More
New Test Identifies Aggressive Breast Cancer
June 23rd 2011The FDA recently approved a new genetic test, called Inform Dual ISH, that helps determine whether women with breast cancer have the human epidermal growth factor receptor 2 (HER2)-positive type.1 In about 20% of breast cancers, the cancer cells produce an excess of the protein HER2 because of a gene mutation. HER2-positive breast cancers tend to be more aggressive and respond less well to hormone therapy.
Read More
Longer Breast-Feeding Tied to More Protective Adipokines
April 19th 2011The duration of breast-feeding is associated with higher maternal ghrelin and pancreatic peptide YY (PYY) levels at three years postpartum, independent of other risk factors for metabolic disease, according to a study published in the April issue of Diabetes.
Read More
AACR: Soy Appears Safe for Breast Cancer Survivors
April 19th 2011Consumption of food containing soy isoflavones does not appear to increase the risk of cancer recurrence or mortality among breast cancer survivors, according to research presented at the annual meeting of the American Association for Cancer Research, held April 2 to 6 in Orlando, Fla.
Read More
Alteration in Health Outcomes Post Estrogen Therapy
April 18th 2011Among postmenopausal women with prior hysterectomy, cessation of conjugated equine estrogen (CEE) therapy reduces the risk of stroke, and the risk of breast cancer remains reduced, according to a study to be published on April 6 in the Journal of the American Medical Association.
Read More
AACR: Breast Cancer Risk Assessed Using Breast Milk
April 18th 2011An individualized screen evaluating epithelial cells from women's breast milk may provide insight into breast cancer risk, according to research presented at the annual meeting of the American Association for Cancer Research, held April 2 to 6 in Orlando, Fla.
Read More
Revisiting the Women’s Health Initiative Estrogen-Alone Trial
April 18th 2011Concern that risks outweighed the possible benefits of estrogen use caused the cessation of the Women's Health Initiative Estrogen-Alone Trial. However, researchers decided to continue monitoring patients for outcomes despite the study protocol discontinuation to gain insight into the long-term effects of the conjugated equine estrogens (CEE) therapy. What they found was surprising-and somewhat positive.
Read More
More Screening Lowers False-Positive Mammography Rate
April 15th 2011U.S. radiologists with higher annual screening volumes and focus have statistically significant lower false-positive rates and cancer detection rates during mammography, according to a study published in the April issue of Radiology.
Read More
Breast Cancer Survival Factors for Underserved Identified
April 15th 2011Advanced stages at presentation, and limited diagnostic and treatment capabilities, contribute to lower breast cancer survival in low-income and middle-income countries (LMC), according to the executive summary of the Breast Health Global Initiative Consensus 2010, published in the April issue of The Lancet Oncology.
Read More
MRI Found to Improve Breast Cancer Detection Rate
April 15th 2011Using a combination of magnetic resonance (MR) imaging and mammography increases sensitivity of cancer detection in women with a history of chest irradiation compared to using either modality on its own, according to a study published in the April issue of Radiology.n
Read More
Pacifier Use Does Not Affect Breast-Feeding Duration
April 13th 2011Pacifier use in healthy, full-term newborns, introduced before or after breast-feeding is established, has little impact on the prevalence or duration of breast-feeding up to four months, according to a review published online in the Cochrane Database of Systematic Reviews.
Read More
Ethnicity Tied to Worry About Breast Cancer Recurrence
April 12th 2011Race and ethnicity have a significant impact on the amount women with breast cancer worry about recurrence, with less acculturated Latina women being especially susceptible to high levels of worry, according to a study published online March 28 in Cancer.
Read More
Libido Unaffected by Endocrine Therapy in Breast Cancer
April 8th 2011Sexual desire in patients with breast cancer is not affected by adjuvant endocrine therapy, but is significantly reduced in those women with chemotherapy- or gonadotropin releasing hormone (GnRH) agonist-induced menopause, according to a study published online March 2 in The Journal of Sexual Medicine.
Read More
Long-Term Tamoxifen Lowers Breast CA Recurrence Risk
April 6th 2011Women with breast cancer who take tamoxifen for five years appear to have a lower risk of recurrence or contralateral breast cancer 15 years after starting treatment as compared to women who take the drug for two years, and they may also have a lower risk of cardiovascular disease and death from a cardiovascular event, according to a study published online March 21 in the Journal of Clinical Oncology.
Read More
Seven-Day On-Off Capecitabine Cycle Treats Breast Cancer
April 5th 2011Treatment of metastatic breast cancer (MBC) with capecitabine administered for seven days followed by seven days of rest in combination with bevacizumab has modest efficacy and minimal toxicity, as predicted previously by mathematical modeling, according to a study published online March 8 in Cancer.
Read More
Tamoxifen Offers Cost-Effective Breast Cancer Prophylaxis
March 30th 2011Tamoxifen chemoprophylaxis is a cost-effective therapy that successfully reduces breast cancer incidence among women younger than 55 years, even after the drug is discontinued, according to a study published online March 14 in Cancer.
Read More
Blacks, Hispanics Face Breast Cancer Treatment Delays
March 28th 2011Black and Hispanic women newly diagnosed with breast cancer are more likely than white women to experience treatment delays of over a month, according to a study published in the February issue of the Journal of Health Care for the Poor and Underserved.
Read More
Obesity Associated With Risk of Dissimilar Breast Cancers
March 24th 2011High body mass index (BMI) and low levels of physical activity are associated with increased risk of triple-negative and estrogen receptor-positive (ER+) breast cancers in postmenopausal women, according to a study published online March 1 in Cancer Epidemiology, Biomarkers & Prevention.
Read More
U.S. Breast Cancer Incidence Rates Stabilized After 2003
March 21st 2011Breast cancer incidence rates among non-Hispanic (NH) white women in the United States stabilized between 2003 and 2007 after a sharp decline between 2002 and 2003 that followed a drop in the use of postmenopausal hormone therapy, according to a study published online Feb. 28 in Cancer Epidemiology, Biomarkers & Prevention.
Read More
Breast-Feeding May Boost Health of Cancer Survivors
March 14th 2011Female childhood cancer survivors should be encouraged to breast-feed as a health behavior that is protective against many late effects of cancer treatment, according to a review published online Jan. 21 in the Journal of Cancer Survivorship.
Read More
Timing of Hormone Therapy Influences Breast Cancer Risk
March 14th 2011For women taking postmenopausal hormone therapy, breast cancer risk is greater among users of estrogen-progestin formulations, and those who begin treatment earlier, according to a study published online Jan. 28 in the Journal of the National Cancer Institute.
Read More
Lower Risk of False Positive With Digital Mammography
March 9th 2011The risk of false-positive results is lower with digital mammography compared to screen-film mammography, with no significant difference in the cancer detection rate between the two, according to a study published in the February issue of Radiology.
Read More